Bringing doctors together

or

A free, private network for verified physicians

  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    PSDr. Paul Sufka
    Leading Voice

    Dr. Paul Sufka

    Rheumatology · General Rheumatology
    Twin Cities Orthopedics
    paulsufka

    Research

    Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer

    2025

    Via Cancer Prev Res (Phila)

    Research

    Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status

    2023

    Via Rheumatology (Oxford, England)

    Research

    Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

    2023

    Via Annals of the Rheumatic Diseases

    Research

    Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand

    2023

    Via The Lancet Regional Health. Western Pacific

    Research

    Industry involvement in rheumatology consensus-based recommendations: a systematic review

    2022

    Via The Lancet. Rheumatology

    Research

    The impact of COVID-19 on rheumatology training — results from the COVID-19 Global Rheumatology Alliance trainee survey

    2022

    Via Rheumatology Advances in Practice

    Research

    COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

    2022

    Via The Lancet. Rheumatology

    Research

    SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry

    2022

    Via RMD Open

    Research

    Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

    2022

    Via Annals of the Rheumatic Diseases

    Research

    Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

    2022

    Via The Lancet. Rheumatology

    Research

    Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

    2022

    Via RMD Open

    Research

    Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

    2022

    Via RMD Open

    Research

    Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry

    2022

    Via ACR Open Rheumatology

    Research

    Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry

    2022

    Via ACR Open Rheumatology

    Research

    Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance

    2022

    Via Arthritis Care & Research